AA	arachidonic acid
AADHAP-R	acyl/alkyl-DHAP reductase
AAG3P-AT	lysophosphatidate acyltransferase
AD	Alzheimer’s disease
AG	alkylglycerols
AGP	1-alkyl-2-lyso-sn-glycero-3-phosphate
AGPS	Alkyl-DHAP synthase
AKT	protein kinase B
BTHS	Barth syndrome
CAD	coronary artery diseases
DHA	docosahexaenoic acid
DHAP	dihydroxyacetone phosphate
EPA	eicosapentaenoic acid
EPT	ethanolamine phosphotransferase
ER	Endoplasmic reticulum
ERK	extracellular signal-regulated kinases
Far1	fatty acyl-CoA reductase 1
GNPAT	glyceronephosphate O-acyltransferase
HG	1-O-hexadecyl-sn-glycerol
MAPK	mitogen-activated protein kinase
MPTP	1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
OeG	1-O-octadecenyl-sn-glycerol
OG	1-O-octadecyl-sn-glycerol
PAP-1	phosphatidate phosphohydrolase 1
PC	phosphatidylcholine
PC-Pls	plasmenyl-PC
PD	Parkinson’s disease
PE	phosphatidylethanolamine
PEDS1	plasmanylethanolamine desaturase 1
PE-Pls	plasmenyl-PE
Pex7	peroxisomal biogenesis factor 7
PI3K	Phosphoinositide 3-kinase
PLA2	phospholipase A2
PLC	phospholipase C
PLD	phospholipase D
pPA	plasmanyl phosphatidic acid
pPE	plasmanyl ethanolamine
PPI-1011	an alkyl-diacyl plasmalogen precursor with DHA at the sn-2 position
PPI-1025	an alkyl-diacyl plasmalogen precursor with oleoyl at the sn-2 position
PPI-1040	a PE-Pls analog with a proprietary cyclic PE headgroup
PRT	plasmalogen replacement therapy
PUFA	Polyunsaturated fatty acids
RCDP	rhizomelic chondrodysplasia punctata
RNS	reactive nitrogen species
ROS	reactive oxygen species
TLR4	Toll-like receptor 4
ZS	Zellweger Syndrome